Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions

Trial ID or NCT#

NCT03486327

Status

not recruiting iconNOT RECRUITING

Purpose

This is an exploratory, single center, open label, parallel-dose, and prospective study of BR55 contrast-enhanced ultrasonography (CEUS) for characterization of solid pancreatic lesions in subjects with suspected pancreatic ductal adenocarcinoma (PDAC) using transabdominal US.

Official Title

Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Walter Park
Walter Park
Gastroenterologist, Pancreas specialist, Gastrointestinal specialist, Pancreatologist
Professor of Medicine (Gastroenterology and Hepatology)
Aya Kamaya
Aya Kamaya
Radiologist
Professor of Radiology (Body Imaging)

Contact us to find out if this trial is right for you.

Contact

Mahima Goel
650.723.0371

View on ClinicalTrials.gov